$HZNP News Stocks are poised for a jump higher 12:30

New Post Public Reply Private Reply Replies (0) Message Board

Jul 9, 2014 at 10:22 AM

$HZNP News

Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
Two health-care names ready to run 12:28 p.m. June 5, 2014 - The Trading Deck
6 stocks to watch 3:13 p.m. June 4, 2014 - The Trading Deck
Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com

A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week 2:11 a.m. July 8, 2014 - Zacks.com
Salix Pharmaceuticals Surges on Positive IBS Data - Analyst Blog 6:15 p.m. July 2, 2014 - Zacks.com
Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog 5:55 p.m. July 2, 2014 - Zacks.com
Hottest Healthcare Stocks Now – IRWD IPXL EXAM HZNP 2:00 p.m. June 19, 2014 - InvestorPlace.com
Horizon finance chief to retire 4:23 p.m. June 18, 2014 - Seeking Alpha
Hard to Find Any Negatives 4:35 p.m. June 17, 2014 - RealMoney.com
Still Churning Higher 1:29 p.m. June 17, 2014 - RealMoney.com
Bear Killers Are on the Hunt 10:22 a.m. June 17, 2014 - RealMoney.com
Hottest Healthcare Stocks Now – EW HZNP PBYI SLXP 7:30 a.m. June 17, 2014 - InvestorPlace.com
Horizon Pharma: Can It Double Again? 4:48 p.m. June 16, 2014 - Seeking Alpha
Why Horizon Pharma (HZNP) Could Be Positioned for a Surge? - Tale of the Tape 8:35 a.m. June 11, 2014 - Zacks.com
Horizon Pharma (HZNP) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape 9:42 a.m. June 2, 2014 - Zacks.com
Substance Over Style: How Niche Companies Alliqua And Horizon Are Being Overlooked 9:42 a.m. May 29, 2014 - Seeking Alpha
Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape 8:57 a.m. May 29, 2014 - Zacks.com
Hottest Healthcare Stocks Now – HZNP MNKD BSX ISIS 1:45 p.m. May 28, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – ISIS CLDX HZNP IDIX 7:45 a.m. May 27, 2014 - InvestorPlace.com
U.S. Firms Pack Up for Tax Benefits 7:36 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition
The 'Inversion' Premium 7:29 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition
Pozen, Inc.: Buy This Biotech For Growth And Income 9:13 a.m. May 10, 2014 - Seeking Alpha
Horizon Pharma Q1 Beats Street; Guidance Mixed 10:12 a.m. May 9, 2014 - Investors Business Daily

Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 6:50 a.m. July 2, 2014 - PR Newswire - PRF
Market Expansion, Merger Agreements, Management Transitions, and Market Activity - Analyst Notes on Intuitive Surgical, Auxilium, Horizon Pharma, Tesaro and ArQule 6:30 a.m. July 2, 2014 - PR Newswire - PRF
Horizon Pharma Announces Execution of $300 Million Senior Secured Credit Agreement in Connection With the Proposed Acquisition of Vidara 7:01 a.m. June 19, 2014 - Marketwire
Horizon Pharma Announces Robert J. De Vaere to Retire and Names Paul W. Hoelscher Chief Financial Officer 7:01 a.m. June 18, 2014 - Marketwire
Horizon Pharma to Present at the JMP Securities Healthcare Conference 2014 3:25 p.m. June 17, 2014 - Marketwire
Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI 6:10 a.m. June 12, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:45 p.m. June 6, 2014 - Marketwire
Top Gainers Roundup -- Research on Horizon Pharma, Celldex Therapeutics, Extreme Networks, and WidePoint 6:17 a.m. May 28, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 27, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:11 p.m. May 23, 2014 - Marketwire
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance 6:31 a.m. May 9, 2014 - Marketwire
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 9, 2014 7:31 a.m. April 25, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:36 p.m. April 23, 2014 - Marketwire
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 11:34 a.m. April 23, 2014 - PR Newswire - PRF
Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board of Directors 7:31 a.m. April 17, 2014 - Marketwire
Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd. 7:31 a.m. April 16, 2014 - Marketwire
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 7:31 a.m. April 10, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Midterm Election Insights: Border Enforcement Debate Heats Up

The Midterm Aftermath: What Really Matters So the ballots are counted, and once again, the shiny chatter about midterms seemed to orbit more around wallet aches and foreign skirmishes than dusty border control debates. But, dig a bit deeper—like poking at a sore spot—and you'll find border security sitting patiently in the wings. Not gone, just waiting for its...

Cognex Delivers Record Q3 Results, Eyes Future Growth

Shaking Up the Leaderboard with Record Revenues You want a testament to a well-oiled machine? Look no further than Cognex Corporation, flaunting a record quarterly revenue hitting $313 million. That's a hearty 13% uptick from last year. Peel back the layers, and excluding a one-time boon from a partnership last year, you're staring at a 19% year-over-year surge. Talk...

Breeze Airways Secures $228M for Fleet Expansion

Breeze Airways and AIP's Milestone Deal Just as the ink is drying on the balance sheets, Breeze Airways is busy making significant moves in the aviation game. Partnering with AIP Capital, they just locked in a $228 million secured debt facility to grab six new Airbus A220-300 aircraft. Now, that’s how you stake your claim in the market. What we’ve got here isn’t...

NIH Seeks AI Solutions for Kidney Disease Breakthroughs

A Cosmic Approach to Kidney Disease When you think about celestial wonders captured by telescopes, the last thing that probably comes to mind is kidney disease. Yet, here we are—with the National Institutes of Health (NIH) issuing a peculiar call to arms: apply astronomy's AI methods to unveil patterns in kidney disease data. It's the kind of inspired lunacy that could...

Cooper Standard Faces Challenges Despite New Business Wins

Cooper Standard's Balancing Act Alright, let’s cut straight to the chase. Cooper Standard (NYSE: CPS) finds itself dabbling in a tricky dance—juggling sparkling new business awards while grappling with stubborn inflationary headwinds and a kick to the shin from production volume shortfalls. Third quarter of 2026, and they reported net new business awards worth a hefty...

Truelink's Strategic Expansion: GES Acquires CSG Creative

Truelink's Big Move in Creative Marketing I don't throw around the word 'synergy' lightly, but this Truelink Capital move has me grudgingly utter it. Picture this: GES, a big dog in event marketing, just grabbed CSG Creative, a firm with its teeth sunk deep into association and event organizer marketing. It sounds like the kind of match you only find lurking in the fancy...

PSG's Anna AI Wins Vizient's Innovative Tech Nod

Hospital Hiring Gets a Tech Boost In the bustling world of healthcare recruitment, it's like trudging through quicksand with a time bomb strapped to your back. That's where PSG Global Solutions sauntered into the Las Vegas spotlight with Anna AI, their generative AI marvel that just snagged the Innovative Technology designation from Vizient. This ain’t your...

Cogent's Q3 2026: A Mixed Bag of Financial Moves

Cogent Communications' Latest Quarter Insights When you hitch your wagon to the communications and internet industry, there's no escaping the hard truths from meticulous quarterly reports. Take Cogent Communications' latest Q3 2026 results, where numbers speak louder than words. Service revenue dipped to $231.2 million for the quarter, a 1.8% drop compared to Q2. And...

Fosun's Strategic Innovations Unveiled at CIIE 2026

Fosun's Nine-Year CIIE Journey Fosun's been trotting out its innovations at the China International Import Expo (CIIE) for nine straight years. With 162 countries in the mix this time around, they're not just playing house—it’s downright world-class boasting. Fosun’s rolling out their hard-hitters in the medical tech space, showing they’re no rookies to the...

Marini SkinSolutions Wins with Night Zyme Complex

Shaking Up the Skincare Scene You don't often see a skincare product snag three prestigious awards in one year, but that's exactly what's unfolding for Marini SkinSolutions. This time, their Night Zyme® Overnight Glass Skin Resurfacing Complex grabbed the 2026 Shop TODAY Ageless Beauty Award. It’s turning heads and not just in beauty aisles but among investors eyeing a...